Search for clinical trials in your area or further afield. We recommend speaking to your medical team if you find a trial you think you may be eligible for.
Researchers in this trial are looking to find out whether a new way of giving carboplatin chemotherapy (adaptive therapy "AT") is as safe as and more effective than the current standard way of giving carboplatin in women with advanced recurrent ovarian cancer.Recurrent ovarian cancer is usually treated with chemotherapy. The chemotherapy aims to ki…
Many people with ovarian cancer are offered genetic testing at diagnosis to see if their cancer is related to an inherited gene mutation (for example a change in the BRCA1 or BRCA2 gene.) Knowing if there are any inherited gene mutations can help doctors offer the best treatment plans, prevent other cancers developing and offer potential testing of…
This study collects information about people who have inherited faulty cancer genes. Inheriting a faulty gene means that a person is at a higher risk of developing certain cancers.A fault in the BRCA1 or BRCA2 genes means that a person is more likely to develop cancers of the breast, ovary or prostate. As well as the BRCA1 and BRCA2 genes, we now k…
In this study researchers are trying to find out why certain cancers stop responding to treatment with the class of drugs called PARP inhibitors.PARP inhibitors are a type of targeted cancer drug. For some women PARP inhibitors stop working and this is known as becoming resistant. Researchers want to collect samples of blood and tumour to find out …
Researchers in this trial are trying to find out the best way to manage ovarian cancer that has spread to the lining of the abdomen (this is called peritoneal metastases). They are testing a new way of delivering cancer medicine (chemotherapy) called PIPAC. This involves spraying chemotherapy onto the peritoneal metastases during keyhole surgery. …
For a woman who's at increased of developing ovarian cancer, the standard practice is to offer an operation to remove both tubes and ovaries (risk reducing salpingo oophorectomy' or RRSO). Removing both tubes and ovaries (RRSO) is at present the most effective or best way we have to prevent ovarian cancer in women who are at increased risk. This is…
Sign up to receive emails and keep up to date on all things Target Ovarian Cancer
Sign up
